Bioalpha Holdings Bhd
KLSE:BIOHLDG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (42.4), the stock would be worth MYR-0.4 (2 091% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -2.1 | MYR0.02 |
0%
|
| Industry Average | 42.4 | MYR-0.4 |
-2 091%
|
| Country Average | 16.5 | MYR-0.16 |
-876%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| MY |
B
|
Bioalpha Holdings Bhd
KLSE:BIOHLDG
|
28.1m MYR | -2.1 | -1 | |
| FR |
|
L'Oreal SA
PAR:OR
|
195.4B EUR | 19.8 | 31.9 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
96.1B GBP | 16.8 | 11.7 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.3T INR | 58.8 | 35.2 | |
| UK |
|
HALEON PLC
LSE:HLN
|
30.6B GBP | 53.2 | 18.4 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
28.7B USD | 21.2 | -161.1 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
15.5B EUR | 67.1 | 16.5 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 25.2 | 22.1 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.1T INR | 73.1 | 59.9 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | 603 | -4 624.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
783.1B INR | 69.8 | 42.5 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 10.7 |
| Median | 16.5 |
| 70th Percentile | 31.5 |
| Max | 143 415.1 |
Other Multiples
Bioalpha Holdings Bhd
Glance View
Bioalpha Holdings Bhd.operates as an investment holding company. The company is headquartered in Bandar Baru Bangi, Selangor. The company went IPO on 2015-04-14. The firm is principally involved in agricultural development, research, and development (R&D), manufacturing, distribution and marketing of functional food and health supplement products under original design manufacturer (ODM) and original brand manufacturer (OBM) basis, as well as operating a retail pharmacy chain under the brand Constant. The Company’s segments includes Trading and manufacturing, which is engaged in research, development, manufacture, importer, exporters, distribution and trader of nutritional and healthcare products; Retail’s pharmacy, which includes Pharmacist, druggist and chemicals, and Others, which is engaged in investment holding and provision of management. The company offers a range of herbs and spices, which includes Tongkat Ali, Kacip Fatimah, Misai Kucing, Hempedu Bumi, Roselle, Dukung Anak and Pecah Beling.
